CHINA RESOURCES SANJIU MEDICAL & PHARMACEUTICAL CO., LTD. China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Stock
Equities
000999
CNE0000011K8
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 59.64 CNY | -0.62% |
|
+5.48% | +19.93% |
| Sales 2024 * | 27.59B 3.81B | Sales 2025 * | 31.23B 4.31B | Capitalization | 58.94B 8.14B |
|---|---|---|---|---|---|
| Net income 2024 * | 3.31B 457M | Net income 2025 * | 3.79B 523M | EV / Sales 2024 * | 2 x |
| Net cash position 2024 * | 3.85B 532M | Net cash position 2025 * | 6.58B 908M | EV / Sales 2025 * | 1.68 x |
| P/E ratio 2024 * |
17.5
x | P/E ratio 2025 * |
15.4
x | Employees | 20,318 |
| Yield 2024 * |
3.08% | Yield 2025 * |
3.17% | Free-Float | 36.9% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.62% | ||
| 1 week | +5.48% | ||
| Current month | +14.94% | ||
| 1 month | +9.37% | ||
| 3 months | +18.88% | ||
| 6 months | +44.90% | ||
| Current year | +19.93% |
1 week
55.00
62.48
1 month
50.3362.48
Current year
48.1262.48
1 year
40.5268.96
3 years
23.3468.96
5 years
23.3468.96
10 years
17.9968.96
| Managers | Title | Age | Since |
|---|---|---|---|
Hua Wei Qiu
CEO | Chief Executive Officer | 57 | 07-12-26 |
Zheng Liang
DFI | Director of Finance/CFO | 46 | 19-10-28 |
Ji Hong Zhang
CMP | Compliance Officer | 53 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Fang Xu
BRD | Director/Board Member | 61 | 18-04-22 |
Hua Wei Qiu
CEO | Chief Executive Officer | 57 | 07-12-26 |
Ying Tan
PRN | Corporate Officer/Principal | 61 | 05-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.83% | 2 M€ | -18.98% | - | |
| 0.69% | 2 M€ | -14.14% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-23 | 59.64 | -0.62% | 7,709,780 |
| 24-04-22 | 60.01 | +1.28% | 10,919,910 |
| 24-04-19 | 59.25 | +2.49% | 7,436,494 |
| 24-04-18 | 57.81 | +0.50% | 5,871,931 |
| 24-04-17 | 57.52 | +1.27% | 5,901,402 |
End-of-day quote Shenzhen S.E., April 22, 2024
More quotes
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. specializes in the development, manufacturing and marketing of pharmaceutical products. The group proposes primarily prescribed drugs, OTC drugs and generic drugs.
Sector
Pharmaceuticals
Calendar
2024-08-21
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
59.64
CNY
Average target price
68.23
CNY
Spread / Average Target
+14.41%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +19.93% | 8.19B | |
| +27.92% | 659B | |
| +27.68% | 557B | |
| -4.59% | 359B | |
| +16.38% | 322B | |
| +9.39% | 297B | |
| +6.30% | 215B | |
| +4.80% | 210B | |
| -6.05% | 200B | |
| -8.58% | 149B |
- Stock Market
- Equities
- 000999 Stock
